Viewing nowIrdin Tablet 2 mg (Irsogladin Maleate)
Irsogladine Maleate 2mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

MFDS item code 201403730 · Approved 2014.08.12 · Insurance code 628900010
Improvement of gastric mucosal lesions in acute gastritis and during acute exacerbations of chronic gastritis; treatment of gastric ulcers
This medication is effective for the treatment of gastric ulcers and is used to improve gastric mucosal lesions such as erosion, bleeding, redness, and swelling during acute exacerbations of acute gastritis and chronic gastritis.
1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosions, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1∼2 divided doses daily.
This medication should not be used by individuals with hereditary conditions such as galactose intolerance, lactase deficiency, or glucose-galactose malabsorption as it contains lactose. While taking this medication, liver function may become abnormal; caution should be exercised if symptoms such as elevated liver enzyme levels or liver dysfunction occur. Gastrointestinal and skin-related side effects such as constipation, rashes, and itching may occur rarely, and immediate consultation with a doctor is necessary if such symptoms appear. Symptoms such as dizziness, drowsiness, loss of appetite, and abdominal bloating have also been reported occasionally, so it is important to monitor one's health closely. Elderly patients may have decreased body function, so when starting this medication, it should be administered slowly from a lower dosage, and their condition should be closely monitored. Pregnant women or those who may become pregnant should only take this medication if the benefits outweigh the risks, as safety during pregnancy has not been sufficiently established. Breastfeeding women should avoid taking this medication if possible since it may be transmitted in small amounts through breast milk, or it is recommended to discontinue breastfeeding while taking the medication. The safety of this medication has not been sufficiently established for children, so it should be used cautiously. This medication should be stored out of the reach of children, and transferring it to another container is not recommended as it may compromise the quality.
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly sealed container to protect it from light and air. It is advisable to maintain a storage temperature between 1°C and 30°C.
White round tablet
30 tablets/bottle, 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowIrsogladine Maleate 2mg
Tablet · Prescription medication
Eden Pharma Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Orally disintegrating Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Dong-gu Bio Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Ilyun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
(Co., Ltd.) Nexpharm Korea
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.